HOME >> BIOLOGY >> NEWS
H Pylori Screening To Reduce The Risk Of Gastric Cancer

ANN ARBOR---Researchers at the University of Michigan have completed a study that provides compelling clinical and economic evidence for population-based Helicobactor pylori (H pylori) screening to reduce the risk of gastric cancer.

Investigators, employing a comprehensive computer analysis, found that H pylori screening could potentially provide important health benefits at a reasonable cost even if elimination of H pylori reduced the increased risk of gastric cancer by only 15 percent in infected individuals.

The study is published in Archives of Internal Medicine.

H pylori's role in most peptic ulcer disease cases has been well documented. People infected with H pylori are also at an increased risk for gastric cancer, prompting the World Health Organization to classify H pylori as a group 1 carcinogen in humans. However, to date, no clinical trial has demonstrated whether the elimination of H pylori infection actually decreases an infected person's already-increased risk for this relatively rare, but frequently lethal, cancer.

"A clinical trial providing definitive evidence that elimination of H pylori infection reduces gastric cancer risk will not be completed for several years," says A. Mark Fendrick, M.D., associate professor of internal medicine in the U-M Health System. "In the interim, we constructed a computer simulation to estimate the potential health and economic consequences of H pylori screening over a range of cancer risk-reduction.

"The ease and low cost of H pylori diagnosis and treatment should make screening attractive to both patients and health care providers. Interestingly, if elimination of H pylori infection reduces cancer risk significantly, this cancer prevention program has the potential to be more cost-effective than mammography and PSA testing."

This is largely due to two factors. First, gastric cancer strikes earlier in life than other common cancers. Therefore, each gastric cancer case prevented led t
'"/>

Contact: Pete Barkey
pbarkey@umich.edu
734-764-2220
University of Michigan
11-Feb-1999


Page: 1 2 3

Related biology news :

1. Study Finds Shorter Period Of Drug Therapy Is Effective In Treating Stomach Ulcers Caused By H. Pylori
2. Society for Biomolecular Screening to hold ninth annual conference
3. Screening technique streamlines search for anticancer drugs
4. Screening certain infants can be lifesaving, Wake Forest study shows
5. Screening embryos for problem chromosomes
6. Screening programs find health problems among former Hanford workers
7. American Red Cross Launches New Genetic Screening Technology To Directly Detect Viruses
8. Vibrating Cells Could Be The Ultimate In Noninvasive Screening
9. Screening In Women Army Recruits Shows High Chlamydia Infection Rates
10. Researchers Develop Fast Screening Method For Water Testing
11. Genetic Screening May Be Tool For Selecting Cancer Treatment, Research Suggests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... ... February 04, 2019 , ... uBiome, the leader microbial ... to help individuals understand how the gut microbes may increase the risk of ... eat foods that contain choline and L-carnitine, such as red meat and eggs, ...
(Date:2/2/2019)... FRANCISCO (PRWEB) , ... January 31, 2019 , ... ... leader in microbial genomics, has awarded microbiome research support in study design, planning, ... Behr, PhD, HCLD, Professor of Obstetrics and Gynecology, and Dr. Sara Vaughn, MD, ...
(Date:1/30/2019)... ... January 30, 2019 , ... ... supports high-growth, high-impact life science and biotechnology companies, announced today that it ... foundations and disease-focused venture funds to discuss their investment philosophies, explain their ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... ... , ... Outsourcing trials to contract research organizations (CRO) can ... creation and management generally requires manual effort. Additionally, each vendor organizes tasks and ... can ultimately lead to study start delays and change orders because tasks were ...
(Date:1/20/2019)... ... ... The American Society of Gene & Cell Therapy (ASGCT) is proud to announce ... 2019. Designed by ASGCT committee volunteers in coordination with patient advocacy groups, the new ... the status and promise of gene and cell therapies. , Gene Therapy 101 ...
(Date:1/11/2019)... ... 2019 , ... Boekel Scientific launches its new Touch Screen ... This advanced and intuitive medical device was designed in conjunction with stationary and ... busiest donor stations with new-to-the industry features to improve efficiency and operational ease. ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... into Noninvasix. This represents the second investment AngelMD has made into Noninvasix in ... Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure brain ...
Breaking Biology Technology:
Cached News: